Supplementary Materials. Prognostic and predictive value of microsatellite instability (MSI) status among patients with colorectal cancer

Supplementary figure 1. Overall survival in (A) stage II CRC and (B) stage III patients according to MSI status.<br>Supplementary figure 2. Stage II CRC with high-risk features.<br>Supplementary figure 3. Overall survival in (A) MSI-H and (B) MSI-S stage II CRC patients with highest-risk features according to chemotherapy.<br>Supplementary figure 4. Stage II CRC without high-risk features.<br>Supplementary figure 5. Overall survival in (A) MSI-H stage III CRC patients with low-risk features and (B) MSI-H stage III CRC patients with high-risk features according to chemotherapy.<br>Supplementary figure A. Patient selection.<br>Supplementary figure B. Histogram for raw data and matched data (stage II MSI-H and high-risk features).<br>Supplementary figure C. Histogram for raw data and matched data (stage II MSI-H and without high-risk features).<br>Supplementary figure D. Histogram for raw data and matched data (stage II MSI-S and without high-risk features).<br>Supplementary Table A. Baseline characteristics of MSI-H stage II CRC patients with high-risk features according to chemotherapy after propensity score matching.<br>Supplementary Table B. Baseline characteristics of MSI-H stage II CRC patients without high-risk features according to chemotherapy after propensity score matching.<br>Supplementary Table C. Baseline characteristics of MSI-L stage II CRC patients without high-risk features according to chemotherapy after propensity score matching.<br>Supplementary Table D. Multivariate analysis for MSI known status stage II &amp; III CRC patients.<br>